Epibiotech Co., Ltd. (XKON:446440)
South Korea
· Delayed Price · Currency is KRW
13,000
+1,000 (8.33%)
At close: Aug 8, 2025
Epibiotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2022 | FY 2021 |
| Aug '25 Aug 7, 2025 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Debt / Equity Ratio | 0.42 | 0.42 | 0.28 |
| Asset Turnover | 0.04 | 0.04 | - |
| Inventory Turnover | 14.21 | 14.21 | - |
| Quick Ratio | 1.29 | 1.29 | 3.37 |
| Current Ratio | 1.37 | 1.37 | 3.80 |
| Return on Equity (ROE) | -62.73% | -62.73% | - |
| Return on Assets (ROA) | -28.39% | -28.39% | - |
| Return on Capital (ROIC) | -29.34% | -29.34% | - |
| Buyback Yield / Dilution | - | -0.60% | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.